Significados de first remission em inglês

There were six cases of early relapse within 1 year of the first remission.

This study quantified the impact of time elapsed in first remission in the same cohort.

Four of 5 patients with ALL, whose bone marrows were collected during first remission, reached CR.

Age, duration of first remission and cytogenetics are the most relevant prognostic factors in relapsed AML.

The first remission after this high dose therapy lasted only 2.5 years.

Eighteen French centers reported 133 autologous stem cell transplantations performed after first remission induction in multiple myeloma.

Administration as maintenance therapy for patients with ovarian cancer in first remission does not prolong RFS or OS.

Seventeen patients were alive in first remission, two were alive in second remission, and nine had died of disease.

A decreased probability of relapse was associated with transplantation in first remission, male patient sex, and grades II-IV acute GVHD.

Conclusion: Duration of first remission remains the most significant predictor of outcome after either BM or isolated EM relapse of SR-ALL.

One was in first remission, another in second remission and five were in relapse at the time of admission for transplant.

We prospectively compared two consecutive cohorts of MM patients in first remission mobilized with G-CSF and non-myelosuppressive chemotherapy with vinorelbine or gemcitabine.

Variables significantly associated with both increased survival and relapse-free survival included transplantation in first remission, younger patient age, and not developing interstitial pneumonia.

Conclusions: These results suggest that bone marrow transplants currently offer no special advantage over chemotherapy for adults with acute lymphoblastic leukemia in first remission.

The relative advantage of transplant from compatible related donors in very-high-risk childhood acute lymphoblastic leukemia was consistent for any time elapsed in first remission.

Our results suggest that delayed neutrophil and platelet recovery is associated with longer OS and TTP in AML patients consolidated with ASCT in first remission.